BioGenerator Company CareSignal Acquired by Lightbeam Health Solutions

BioGenerator Company Wugen Raises $172 Million to Advance Memory NK Cell Platform, AML Program, and Initiate Multiple Solid Tumor Trials

BioGenerator Company Geneoscopy Enrolls First Patients in CRC-PREVENT U.S. Pivotal Trial

› PR Newswire

BioGenerator Company Aclaris Therapeutics Announces Positive Data from Trial in Atopic Dermatitis

› Biospace

BioGenerator Company Galera Therapeutics Announces Updated Data from Pancreatic Cancer Trial

BioGenerator Company Arch Oncology Closes $105M Series C Financing

BioGenerator Company Neurolutions Receives FDA Authorization For Brain-Computer-Interface Device

BioGenerator Company Cardialen Announces Positive Results from Clinical Study for Atrial Fibrillation

BioGenerator Company SentiAR Closes Oversubscribed $5.1M Series A led by Techwald Holding